Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Teramoto, S
The programme spans multiple trials targeting distinct endpoints: On 21 May 2026 Eli Lilly reported topline results from TRIUMPH-1, the pivotal Phase 3 obesity trial and the programme's first Phase 3 efficacy readout: in 2,339 adults, mean weight loss at the 80-week primary endpoint reached 19.0% (4mg), 25.9% (9mg), and 28.3% (12mg) versus 2.2% for placebo (Eli Lilly investor release
Focus on hydration and consider herbal support like milk thistle or dandelion root
Vial size and treatment length are set in clinic
Why does COA verification matter
US$ 23.45
US$ 21.91
US$ 28.50
US$ 28.90
US$ 24.79
US$ 27.86
US$ 23.57
US$ 21.89
US$ 21.35
US$ 25.98
US$ 28.39
US$ 26.91
US$ 20.47
US$ 28.89
